Published in J Neurol on January 01, 1984
Alcohol-induced IL-1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation. J Leukoc Biol (2013) 1.10
Improvement in memory and static balance with abstinence in alcoholic men and women: selective relations with change in brain structure. Psychiatry Res (2007) 1.05
Neurologic effects of alcoholism. West J Med (1994) 1.01
Long latency EMG responses in hand and leg muscles: cerebellar disorders. J Neurol Neurosurg Psychiatry (1987) 0.92
An update on the cerebellar subtype of multiple system atrophy. Cerebellum Ataxias (2014) 0.91
Pontocerebellar volume deficits and ataxia in alcoholic men and women: no evidence for "telescoping". Psychopharmacology (Berl) (2009) 0.90
Persistent but less severe ataxia in long-term versus short-term abstinent alcoholic men and women: a cross-sectional analysis. Alcohol Clin Exp Res (2011) 0.83
Mechanisms of postural control in alcoholic men and women: biomechanical analysis of musculoskeletal coordination during quiet standing. Alcohol Clin Exp Res (2009) 0.80
Ataxia. Neurol Clin (2015) 0.77
Acquired ataxias: the clinical spectrum, diagnosis and management. J Neurol (2015) 0.77
Molecular and neurologic responses to chronic alcohol use. Handb Clin Neurol (2014) 0.76
Perspectives on fronto-fugal circuitry from human imaging of alcohol use disorders. Neuropharmacology (2017) 0.75
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci (1996) 6.12
MIF as a glucocorticoid-induced modulator of cytokine production. Nature (1995) 5.21
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia (2010) 3.54
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet (2000) 3.33
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Glutathione, oxidative stress and neurodegeneration. Eur J Biochem (2000) 3.11
Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol (1998) 3.09
Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet (1999) 2.81
Cholesterol and Alzheimer's disease: is there a link? Neurology (2001) 2.79
Brain stem activation in spontaneous human migraine attacks. Nat Med (1995) 2.67
Influence of central set on human postural responses. J Neurophysiol (1989) 2.66
Postural strategies associated with somatosensory and vestibular loss. Exp Brain Res (1990) 2.54
Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke (2001) 2.45
The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A (1997) 2.36
Cerebellar encephalitis in adults. J Neurol (1993) 2.30
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2001) 2.29
Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res (2001) 2.26
The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain (1998) 2.11
An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med (1999) 2.10
Oxidative stress in patients with Friedreich ataxia. Neurology (2000) 2.03
MRI atlas of the human cerebellar nuclei. Neuroimage (2002) 2.00
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med (1996) 1.99
Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98
Differential effects of central verses peripheral vision on egocentric and exocentric motion perception. Exp Brain Res (1973) 1.98
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med (1997) 1.86
Recovery from Wernicke's aphasia: a positron emission tomographic study. Ann Neurol (1995) 1.86
Dissociation of the lateral and medial cerebellum in movement timing and movement execution. Exp Brain Res (1988) 1.82
Tremor-correlated cortical activity in essential tremor. Lancet (2001) 1.82
Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J Neurochem (2000) 1.78
Cerebellar control of postural scaling and central set in stance. J Neurophysiol (1994) 1.75
An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci U S A (1999) 1.74
Gray matter decrease in patients with chronic tension type headache. Neurology (2005) 1.71
Visual control of arm movement in Parkinson's disease. Mov Disord (1994) 1.69
Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology (2001) 1.68
Moving visual scenes influence the apparent direction of gravity. Science (1972) 1.62
Localization of a cerebellar timing process using PET. Neurology (1995) 1.62
[Pain treatment facilities in Germany. Ambulatory, day care and inpatient facilities for patients with chronic pain]. Schmerz (2004) 1.61
Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology (2002) 1.60
Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol (1984) 1.57
Prevalence of cluster headache in a population-based sample in Germany. Cephalalgia (2007) 1.56
Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology (1993) 1.55
Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia (2007) 1.52
Quantitative analysis of stance in late cortical cerebellar atrophy of the anterior lobe and other forms of cerebellar ataxia. Brain (1979) 1.51
The significance of proprioception on postural stabilization as assessed by ischemia. Brain Res (1984) 1.48
Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Stroke (2000) 1.47
Anticipation in familial cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand (1998) 1.46
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.45
Epidemiology of chronic daily headache. Eur J Med Res (2003) 1.45
Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis. Eur J Neurol (2009) 1.44
Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol (1999) 1.44
Cerebellar ataxia in ataxic hemiparesis? A kinematic and EMG analysis. Mov Disord (1993) 1.43
Symptomatic migraine and pontine vascular malformation: evidence for a key role of the brainstem in the pathophysiology of chronic migraine. Cephalalgia (2006) 1.43
[Recent new information on epidemiology of headache]. Fortschr Neurol Psychiatr (2004) 1.42
Mechanisms underlying recovery of eye-head coordination following bilateral labyrinthectomy in monkeys. Exp Brain Res (1973) 1.42
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry (1994) 1.41
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol (1996) 1.40
[Postpoliomyelitis syndrome]. Dtsch Med Wochenschr (1994) 1.39
[Neuronal protection in neurologic diseases?]. Nervenarzt (1994) 1.38
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology (2011) 1.36
Brain representation of active and passive movements. Neuroimage (1996) 1.36
Manifestation of Hashimoto's encephalopathy years before onset of thyroid disease. Eur Neurol (1999) 1.36
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology (2004) 1.36
Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol (1995) 1.35
The aetiology of sporadic adult-onset ataxia. Brain (2002) 1.34
Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun (1999) 1.33
On the role of vestibular, visual and somatosensory information for dynamic postural control in humans. Prog Brain Res (1988) 1.31
BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry (1999) 1.29
The development toward stereotypic arm kinematics during reaching in the first 3 years of life. Exp Brain Res (1997) 1.29
Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1997) 1.28
Dynamic cerebral autoregulation in acute ischemic stroke assessed from spontaneous blood pressure fluctuations. Stroke (2005) 1.28
Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol (2002) 1.28
Arm training induced brain plasticity in stroke studied with serial positron emission tomography. Neuroimage (2001) 1.26
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene (2000) 1.26
Early stabilization of human posture after a sudden disturbance: influence of rate and amplitude of displacement. Exp Brain Res (1984) 1.25
Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int J Cancer (1998) 1.25
Hypothalamic deep brain stimulation for cluster headache: experience from a new multicase series. Cephalalgia (2008) 1.24
A defect of kinesthesia in Parkinson's disease. Mov Disord (1995) 1.23
Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain (1998) 1.23
Bisamides, lignans, triterpenes, and insecticidal Cyclopenta[b]benzofurans from Aglaia species. J Nat Prod (1998) 1.22
Variability of postural "reflexes" in humans. Exp Brain Res (1983) 1.22
Some methods and parameters of body sway quantification and their neurological applications. Arch Psychiatr Nervenkr (1970) (1980) 1.22
Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol (1999) 1.21
Evolution of functional reorganization in hemiplegic stroke: a serial positron emission tomographic activation study. Ann Neurol (1999) 1.21
The effect of lateral head tilt on horizontal postrotatory nystagmus I and II and the Purkinje effect. Acta Otolaryngol (1985) 1.20
The development of goal-directed reaching in infants: hand trajectory formation and joint torque control. Exp Brain Res (1995) 1.20
Reflex activation of muscle spindles in human pretibial muscles during standing. J Neurophysiol (1990) 1.20
Classical conditioning after cerebellar lesions in humans. Behav Neurosci (1993) 1.19
Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol (2008) 1.19
Characteristic alterations of long-loop "reflexes" in patients with Friedreich's disease and late atrophy of the cerebellar anterior lobe. J Neurol Neurosurg Psychiatry (1984) 1.19